Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Lottermoser K, Vetter H, Düsing R . Blood pressure-independent atherogenic and thromboembolic mechanisms of the renin–angiotensin–aldosterone system. J Clin Basic Cardiol 2001; 4: 89.
2. Dandona P, Kumar V, Al-Jada A, Ghanim H, Syed T, Hofmayer D et al. Angiotensin II receptor blocker valsartan supresses reactive oxygen species generation in leukocytes, nuclear factor-κB, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. J Clin Endocrinol Metab 2003; 88 (9): 4496–4501.
3. Zhuo JL . Monocyte chemoattractant protein-1: a key mediator of angiotensin II-induced target organ damage in hypertensive heart disease? J Hypertens 2004; 22: 451–454.
4. Nakamura S, Nakamura I, Ma L, Vaughan DE, Fogo AB . Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int 2000; 58: 251–259.
5. Brown NJ, Agirbasli MA, Williams GH, Litchfield WR, Vaughan DE . Effect of activation and inhibition of the renin–angiotensin system on plasma PAI-1. Hypertension 1998; 32: 965–971.
Cited by
91 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献